Dorrie Rizzo1,2, Eva Libman2,3, Marc Baltzan4,5,6,7, Catherine Fichten2,3, Sally Bailes2,3. 1. Department of Family Medicine, McGill University, Montréal, Québec, Canada. 2. Centre Intégré Universitaire des Soins et Services Sociaux de l'ouest de l'île, Lady Davis Institute for Medical Research, Montréal, Québec, Canada. 3. Department of Psychiatry, McGill University, Montréal, Québec, Canada. 4. Faculty of Medicine, Department of Epidemiology Biostatistics and Occupational Health, McGill University, Montréal, Canada. 5. Centre Intégré Universitaire des Soins et Services Sociaux du Nord de L'île de Montréal, Montréal, Canada. 6. Mount Sinai Hospital, Centre Intégré Universitaire des Soins et Services Sociaux du Centre-ouest de L'île de Montréal, Montréal, Canada. 7. Institut de Médecine du Sommeil, Montréal, Canada.
Abstract
STUDY OBJECTIVES: In the context of the current COVID-19 pandemic situation, we address the following important questions: (1) How can patients be identified for possible OSA while sleep clinic testing is temporarily unavailable or limited? and (2) What measures can be suggested to improve sleep health until proper diagnosis and treatment become safe and available again? METHODS: As a proxy for home or in-laboratory testing, validation of a symptom-based measure of OSA risk is presented, based on an ongoing larger prospective study of 156 family medicine patients with OSA (88 women, 68 men; mean age, 57 years) and 60 control participants (36 women, 24 men; mean age, 54 years) recruited from the community. Participants completed the Sleep Symptom Checklist (SSC) and a range of other self-report measures; primary care patients also underwent a polysomnographic sleep study. RESULTS: Results showed that (1) individuals with OSA reported more symptoms on the SSC related to insomnia, daytime symptoms, sleep disorders, and psychological maladjustment than did the control group (all P < .001), and (2) their sleep-related symptoms were significantly more severe than those of the control patients. In addition, several polysomnographic indices in recently diagnosed untreated individuals with OSA were significantly correlated with SSC measured sleep disorder symptoms, and SSC scores significantly distinguished participants with OSA from control participants. CONCLUSIONS: Our findings suggest that family practitioners can effectively prescreen patients for possible OSA by inquiring about 5 items that form the SSC sleep disorders subscale. If OSA is suspected, then we can recommend a range of behavioral techniques to improve symptoms. The current pandemic causes us to reflect that the provisional targeting of symptoms and guidance regarding mitigation strategies while waiting for specialist care could serve patients well at any time.
STUDY OBJECTIVES: In the context of the current COVID-19 pandemic situation, we address the following important questions: (1) How can patients be identified for possible OSA while sleep clinic testing is temporarily unavailable or limited? and (2) What measures can be suggested to improve sleep health until proper diagnosis and treatment become safe and available again? METHODS: As a proxy for home or in-laboratory testing, validation of a symptom-based measure of OSA risk is presented, based on an ongoing larger prospective study of 156 family medicine patients with OSA (88 women, 68 men; mean age, 57 years) and 60 control participants (36 women, 24 men; mean age, 54 years) recruited from the community. Participants completed the Sleep Symptom Checklist (SSC) and a range of other self-report measures; primary care patients also underwent a polysomnographic sleep study. RESULTS: Results showed that (1) individuals with OSA reported more symptoms on the SSC related to insomnia, daytime symptoms, sleep disorders, and psychological maladjustment than did the control group (all P < .001), and (2) their sleep-related symptoms were significantly more severe than those of the control patients. In addition, several polysomnographic indices in recently diagnosed untreated individuals with OSA were significantly correlated with SSC measured sleep disorder symptoms, and SSC scores significantly distinguished participants with OSA from control participants. CONCLUSIONS: Our findings suggest that family practitioners can effectively prescreen patients for possible OSA by inquiring about 5 items that form the SSC sleep disorders subscale. If OSA is suspected, then we can recommend a range of behavioral techniques to improve symptoms. The current pandemic causes us to reflect that the provisional targeting of symptoms and guidance regarding mitigation strategies while waiting for specialist care could serve patients well at any time.
Authors: Joseph Barker; Oluwatobiloba Oyefeso; David Koeckerling; Nadeesha Lakmal Mudalige; Daniel Pan Journal: Thorax Date: 2020-04-09 Impact factor: 9.139
Authors: Najib Ayas; Robert Skomro; Adam Blackman; Kristen Curren; Michael Fitzpatrick; John Fleetham; Charles George; Tom Hakemi; Patrick Hanly; Christopher Li; Debra Morrison; Frédéric Series Journal: Can Respir J Date: 2014 Mar-Apr Impact factor: 2.409
Authors: Vivek N Prachand; Ross Milner; Peter Angelos; Mitchell C Posner; John J Fung; Nishant Agrawal; Valluvan Jeevanandam; Jeffrey B Matthews Journal: J Am Coll Surg Date: 2020-04-09 Impact factor: 6.113
Authors: P-L Bastier; N Aisenberg; F Durand; P Lestang; D Abedipour; O Gallet de Santerre; V Couloigner; E Bequignon Journal: Eur Ann Otorhinolaryngol Head Neck Dis Date: 2020-05-11 Impact factor: 2.080